RBP4 and acute coronary syndrome: Combining RBP4 with other biomarkers improves prognostic accuracy for adverse cardiovascular events (Flores-Cortez et al., 2022; Ye et al., 2023), and an RBP4-based multimarker score has been proposed as a prognostic tool for patients with acute coronary syndrome (Ye et al., 2023).